Stay updated on Patisiran for hATTR Amyloidosis Clinical Trial
Sign up to get notified when there's something new on the Patisiran for hATTR Amyloidosis Clinical Trial page.

Latest updates to the Patisiran for hATTR Amyloidosis Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedAdded the topic keyword 'Amyloidosis' and updated the page revision from v3.4.1 to v3.4.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check20 days agoChange DetectedMinor version update from v3.4.0 to v3.4.1; no changes to core study content or participant information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check27 days agoChange DetectedUI updates include a Show glossary option and changes to metadata labels (e.g., 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0'), with capitalization tweaks like 'No FEAR Act Data'. These are cosmetic changes that do not affect study content or eligibility information.SummaryDifference0.3%

- Check42 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4 across the page. This appears to be a minor software revision with no changes to study details or user-facing functionality.SummaryDifference0.1%

- Check63 days agoChange DetectedFooter updated: added Revision: v3.3.3; removed HHS Vulnerability Disclosure and Revision: v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check92 days agoChange DetectedPublications section now states that items are automatically filled from PubMed, and a UI revision note shows Revision: v3.3.2 (replacing v3.2.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Patisiran for hATTR Amyloidosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Patisiran for hATTR Amyloidosis Clinical Trial page.